About the Authors
- Alexey V. Gribenko
-
* E-mail: alexey.gribenko@pfizer.com
Affiliation Pfizer Vaccine Research and Development, Pearl River, New York, United States of America
- Kevin Parris
-
Affiliation Pfizer Protein Engineering and Production, Cambridge, Massachusetts, United States of America
- Lidia Mosyak
-
Affiliation Pfizer Protein Engineering and Production, Cambridge, Massachusetts, United States of America
- Sheng Li
-
Affiliation Department of Medicine, University of California at San Diego, La Jolla, California, United States of America
- Luke Handke
-
Affiliation Pfizer Vaccine Research and Development, Pearl River, New York, United States of America
- Julio C. Hawkins
-
Affiliation Pfizer Vaccine Research and Development, Pearl River, New York, United States of America
- Elena Severina
-
Affiliation Pfizer Vaccine Research and Development, Pearl River, New York, United States of America
- Yury V. Matsuka
-
Affiliation Pfizer Vaccine Research and Development, Pearl River, New York, United States of America
- Annaliesa S. Anderson
-
Affiliation Pfizer Vaccine Research and Development, Pearl River, New York, United States of America
Competing Interests
I have read the journal's policy and the authors of the manuscript have the following competing interests: AVG, KP, LM, LH, ES, YVM, JCH and ASA are current or former employees of Pfizer Inc and as such may own company stock. SL has no competing interests.
Author Contributions
Conceptualization: AVG ASA. Formal analysis: AVG KP LM JCH ES YVM. Investigation: AVG ES KP LM SL JCH LH. Methodology: AVG SL ES YVM JCH LH KP LM. Project administration: AVG ASA. Supervision: AVG ASA. Validation: AVG ES. Visualization: AVG ES JCH KP. Writing – original draft: AVG. Writing – review & editing: AVG YVM ASA SL LM LH.